CAS 222018-18-0 Lyn Peptide Inhibitor TFA

Send Inquiry
CAS 222018-18-0 Lyn Peptide Inhibitor TFA
Details
•CAS Number: 222018-18-0
•Synonyms: Lyn kinase inhibitory peptide; Lyn peptide inhibitor (TFA salt)
•Amino Acid Sequence: Stearoyl-Tyr-Gly-Tyr-Arg-Leu-Arg-Arg-Lys-Trp-Glu-Glu-Lys-Ile-Pro-Asn-Pro-NH₂ (one-letter: Stearoyl-YGYRLRRKWEEKIPNP-NH₂)
•Peptide Length: 16 amino acids (N-terminal stearoylated, C-terminal amidated)
•Purity (HPLC): ≥95%
•Salt Form: Trifluoroacetate (TFA)
Related Documents
•Certificate of Analysis (COA)
•Mass Spectrometry (MS) Report
•HPLC Purity Report
•Peptide Solubility and Storage Guide
Category
Drug Delivery Peptides
Share to
Description

Shanghai Sonyt Biotechnology Co., Ltd. is one of the leading manufacturers and suppliers of cas 222018-18-0 lyn peptide inhibitor tfa in China, also supports custom service. Welcome to wholesale bulk high quality cas 222018-18-0 lyn peptide inhibitor tfa from our factory. Contact us for more details.

 

Description Lyn peptide inhibitor TFA is a potent and cell-permeable inhibitor of the Lyn-coupled IL-5 receptor signaling pathway. Lyn is a Src family tyrosine kinase that plays a key role in IL-3, GM-CSF, and IL-5 receptor signaling. This inhibitory peptide blocks the binding of Lyn tyrosine kinase to the βc subunit of IL-3/GM-CSF/IL-5 receptors, thereby inhibiting Lyn activation while keeping other signaling pathways intact. N-terminal stearoylation enhances the peptide's cell-penetrating ability and membrane affinity, and C-terminal amidation improves metabolic stability. In vitro, this peptide inhibits IL-5 receptor-mediated eosinophil differentiation and survival; in a mouse asthma model, it inhibits airway eosinophilic inflammation. This product is suitable for research on asthma, allergic diseases, and other eosinophil-related disorders.
Molecular formula C₁₁₅H₁₈₄N₃₀O₂₄ (free base)
Molecular weight (Da) 2370.88 (free base); 2484.91 (TFA salt)
Structure type Linear peptide (N-terminal stearoylated, C-terminal amidated)
Solubility Freely soluble in water (10 mg/mL), PBS
Storage Condition Powder at -20°C, dry and protected from light

 

Product Basic Information Table

 

Product Standard English Name Product Abbreviation / Alias Function Tags (comma-separated) Core Structure Molecular Formula Exact Mass (Da) Average MW (Da) Salt Form Length (aa)
Lyn peptide inhibitor TFA Lyn kinase inhibitory peptide TFA; Src family kinase inhibitor peptide Tyrosine kinase inhibitor, Lyn kinase blockade, signaling pathway study, anti-inflammatory & anti-tumor Inhibitory peptide derived from the autoregulatory domain of Lyn tyrosine kinase; competitively binds the SH2/SH3 domains of Lyn to inhibit kinase activity and downstream signaling; used for B cell signaling, tumorigenesis and inflammation research C₅₈H₈₃N₁₃O₁₃·xTFA 1177.62 (free peptide) ~1178.7 (free peptide) Trifluoroacetate (TFA) 10

 

Physicochemical Solubility & Storage Parameters

 

Product Code Appearance Long-term Storage Short-term Storage Solution Stability Solid Powder Stability
PEP-LYN-I White powder Store at -20°C, sealed, dry and protected from light. Aliquot for storage. Stable for 1 month at 2–8°C in sealed dry condition; stable for shipping at ambient temperature. Stable for 7 days at 4°C. TFA salt is readily soluble in water, dilute acetic acid and PBS. Optimal kinase binding activity at physiological pH; conformational change and inhibitory activity loss under strong acid/base conditions. Stable for 2 years at -20°C, dry and protected from light.

Functional Description

 

Product Code Frontend Short Summary (for search list display) Detailed Biological Function Description Applicable Research Areas (comma-separated) Targets / Pathways
PEP-LYN-I Lyn kinase inhibitory peptide competitively blocks Src family kinase activity Lyn kinase inhibitory peptide is a competitive inhibitor peptide derived from the autoregulatory domain of Lyn tyrosine kinase. It mimics the endogenous regulatory mechanism to bind the SH2/SH3 domains of Lyn kinase, blocking kinase activation and downstream signal transduction. It is used for studies of B cell receptor signaling, mast cell activation, tumor proliferation and inflammatory responses. Kinase signaling pathway research, B cell immunology, anti-tumor drug development, inflammatory disease research, Src family kinases Lyn tyrosine kinase SH2/SH3 domains; kinase active site; B cell receptor signaling pathway

 

 

 

 

Hot Tags: cas 222018-18-0 lyn peptide inhibitor tfa, China cas 222018-18-0 lyn peptide inhibitor tfa manufacturers, suppliers, factory, 203716-10-3, 651328-78-8, 997-20-6, CAS 203716 10 3, HIV 1 Tat Protein Peptide 47 57 , NGR peptide

Send Inquiry